IA
TERN

IFP Advisors’s Terns Pharmaceuticals TERN Stock Holding History

IFP Advisors’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.4K Hold
1,424
– – ﹤0.01% 2157
2026
Q1 		$75.1K Buy
+1,424
New +$58.5K ﹤0.01% 2019
2025
Q2 		– Hold
0
– – – 4523
2025
Q1 		– Sell
-114
Closed -$466 – 4225
2024
Q4 		$675 Buy
+114
New +$772 ﹤0.01% 3355

IFP Advisors's TERN Position: Q2 2026 in Review

IFP Advisors held its Terns Pharmaceuticals (TERN) position steady in Q2 2026 at 1,424 shares worth $75.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2157.

IFP Advisors first reported a position in TERN in Q4 2024 and has held it in 3 quarters since. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • IFP Advisors held 1,424 shares of Terns Pharmaceuticals worth $75.4K as of Q2 2026.
  • IFP Advisors left its Terns Pharmaceuticals share count unchanged in Q2 2026.
  • Terns Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2157 holding.
  • IFP Advisors first reported a position in Terns Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.